Strategic Partnerships Creso Pharma actively engages in partnerships across pharmaceuticals, distribution, and psychedelic/psilocybin segments, signaling opportunities to position co-branded or licensed cannabis, hemp, or psychedelic-derived products in markets with compliance pathways.

Geographic Expansion With operations and activity across Australia, Canada, and anticipated EU/GMP engagements, there are sales opportunities to introduce research-backed cannabis and hemp products into new regional channels, including veterinary and human health sectors.

Animal & Vet Focus Creso emphasizes pharmaceutical rigor for products in both human and animal health, suggesting a potential to sell regulated veterinary cannabis/derivative products or nutraceuticals to veterinary clinics, pet care retailers, and animal health distributors.

Funding & Growth Recent financing and convertible notes indicate liquidity events and growth phases; sales teams can target strategic distributors and investment-backed channels looking for vetted, science-driven cannabis/hemp portfolios.

Diverse Product Pipeline From Green Goo launches to Halucenex Life Sciences’ psilocybin derivatives, there are multiple adjacent product lines and partnerships that can be leveraged for cross-sell opportunities with specialty distributors and pharmaceutical-grade channels.